Microscopic colitis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{SI}}
{{CMG}}
{{CMG}}
{{SK}}


==Overview==
==Overview==
{{SI}}
 
'''Microscopic colitis''' refers to two medical conditions which cause [[diarrhoea]]: [[collagenous colitis]] and [[lymphocytic colitis]]. Both conditions are characterised by the following triad of clinicopathological features:  
'''Microscopic colitis''' refers to two medical conditions which cause [[diarrhoea]]: [[collagenous colitis]] and [[lymphocytic colitis]]. Both conditions are characterised by the following triad of clinicopathological features:  
# Chronic watery diarrhoea;  
# Chronic watery diarrhoea;  
Line 9: Line 12:
# Characteristic [[histopathology]].
# Characteristic [[histopathology]].


== Clinical features ==
==Historical Perspective==
Patients are characteristically, though not exclusively, middle-aged [[female]]s. They present with a long history of watery diarrhoea, which may be profuse. There is a higher incidence of [[autoimmune disease]]s, for example [[arthritis]], [[Sjögren's syndrome]], and [[coeliac disease]], in patients with microscopic colitis. There are reports of associations with multiple drugs, especially non-steroidal anti-inflammatory drugs ([[NSAID]]s).


Colonoscopy is normal or near normal. The changes are often patchy, so multiple colonic biopsies must be taken in order to make the diagnosis.{{Fact|date=February 2007}} A full colonoscopy is required, as an examination limited to the rectum will miss cases of microscopic colitis.
==Classification==


== Pathology ==
==Pathophysiology==
The hallmark of microscopic colitis is an increase in inflammatory cells (i.e. [[lymphocytes]]) in colonic [[biopsies]] with an otherwise normal appearance and architecture of the colon. Inflammatory cells are increased both in the surface [[epithelium]] ("intraepithelial lymphocytes") and in the [[lamina propria]]. In lymphocytic colitis, these are the only abnormal features.
The hallmark of microscopic colitis is an increase in inflammatory cells (i.e. [[lymphocytes]]) in colonic [[biopsies]] with an otherwise normal appearance and architecture of the colon. Inflammatory cells are increased both in the surface [[epithelium]] ("intraepithelial lymphocytes") and in the [[lamina propria]]. In lymphocytic colitis, these are the only abnormal features.


Line 21: Line 23:
Microscopic colitis in some cases may be an adverse reaction to drugs or an autoimmune disorder.<ref name="pmid25001258">{{cite journal| author=Macaigne G, Lahmek P, Locher C, Lesgourgues B, Costes L, Nicolas MP et al.| title=Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study. | journal=Am J Gastroenterol | year= 2014 | volume= 109 | issue= 9 | pages= 1461-70 | pmid=25001258 | doi=10.1038/ajg.2014.182 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25001258  }} </ref>
Microscopic colitis in some cases may be an adverse reaction to drugs or an autoimmune disorder.<ref name="pmid25001258">{{cite journal| author=Macaigne G, Lahmek P, Locher C, Lesgourgues B, Costes L, Nicolas MP et al.| title=Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study. | journal=Am J Gastroenterol | year= 2014 | volume= 109 | issue= 9 | pages= 1461-70 | pmid=25001258 | doi=10.1038/ajg.2014.182 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25001258  }} </ref>


== Treatment ==
==Causes==
 
==Differentiating Microscopic Colitis from other Diseases==
 
==Epidemiology and Demographics==
 
===Age===
Patients are characteristically middle-aged.
===Gender===
Patients are characteristically, though not exclusively female.
===Race===
 
==Risk Factors==
 
==Natural History, Complications and Prognosis==
The prognosis for lymphocytic colitis and collagenous colitis is good and both conditions are considered to be benign.<ref name=mullhaupt>{{cite journal | author = Mullhaupt B, Güller U, Anabitarte M, Güller R, Fried M | title = Lymphocytic colitis: clinical presentation and long term course. | journal = Gut | volume = 43 | issue = 5 | pages = 629-33 | year = 1998 | id = PMID 9824342}}</ref>  The majority of people afflicited with the conditions recover from their diarrhoea and their histological abnormalities resolve.<ref name=fernandez/>
 
==Diagnosis==
===Diagnostic Criteria===
===Symptoms===
===Physical Examination===
===Laboratory Findings===
===Imaging Findings===
===Other Diagnostic Studies===
Colonoscopy is normal or near normal. The changes are often patchy, so multiple colonic biopsies must be taken in order to make the diagnosis. A full colonoscopy is required, as an examination limited to the rectum will miss cases of microscopic colitis.
 
==Treatment==
===Medical Therapy===
No single treatment is accepted as the standard and measuring response is difficult. Often a trial of [[anti-diarrhoeal]]s is followed by [[anti-inflammatory drug]]s.  
No single treatment is accepted as the standard and measuring response is difficult. Often a trial of [[anti-diarrhoeal]]s is followed by [[anti-inflammatory drug]]s.  


Lymphocytic colitis is thought to respond well to [[mesalazine]] and collagenous colitis to [[budesonide]].<ref name=fernandez>{{cite journal | author = Fernández-Bañares F, Salas A, Esteve M, Espinós J, Forné M, Viver J | title = Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up. | journal = Am J Gastroenterol | volume = 98 | issue = 2 | pages = 340-7 | year = 2003 | id = PMID 12591052}}</ref>
Lymphocytic colitis is thought to respond well to [[mesalazine]] and collagenous colitis to [[budesonide]].<ref name=fernandez>{{cite journal | author = Fernández-Bañares F, Salas A, Esteve M, Espinós J, Forné M, Viver J | title = Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up. | journal = Am J Gastroenterol | volume = 98 | issue = 2 | pages = 340-7 | year = 2003 | id = PMID 12591052}}</ref>


==Prognosis==
===Surgery===
The prognosis for lymphocytic colitis and collagenous colitis is good and both conditions are considered to be benign.<ref name=mullhaupt>{{cite journal | author = Mullhaupt B, Güller U, Anabitarte M, Güller R, Fried M | title = Lymphocytic colitis: clinical presentation and long term course. | journal = Gut | volume = 43 | issue = 5 | pages = 629-33 | year = 1998 | id = PMID 9824342}}</ref>  The majority of people afflicited with the conditions recover from their diarrhoea and their histological abnormalities resolve.<ref name=fernandez/>
===Prevention===
 
==See also==
*[[Colitis]]


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
==External links==
[[Category:Gastroenterology]]
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]
[[Category:Disease]]


{{WH}}
{{WH}}
{{WikiDoc Sources}}
{{WS}}

Latest revision as of 20:31, 5 July 2016

WikiDoc Resources for Microscopic colitis

Articles

Most recent articles on Microscopic colitis

Most cited articles on Microscopic colitis

Review articles on Microscopic colitis

Articles on Microscopic colitis in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Microscopic colitis

Images of Microscopic colitis

Photos of Microscopic colitis

Podcasts & MP3s on Microscopic colitis

Videos on Microscopic colitis

Evidence Based Medicine

Cochrane Collaboration on Microscopic colitis

Bandolier on Microscopic colitis

TRIP on Microscopic colitis

Clinical Trials

Ongoing Trials on Microscopic colitis at Clinical Trials.gov

Trial results on Microscopic colitis

Clinical Trials on Microscopic colitis at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Microscopic colitis

NICE Guidance on Microscopic colitis

NHS PRODIGY Guidance

FDA on Microscopic colitis

CDC on Microscopic colitis

Books

Books on Microscopic colitis

News

Microscopic colitis in the news

Be alerted to news on Microscopic colitis

News trends on Microscopic colitis

Commentary

Blogs on Microscopic colitis

Definitions

Definitions of Microscopic colitis

Patient Resources / Community

Patient resources on Microscopic colitis

Discussion groups on Microscopic colitis

Patient Handouts on Microscopic colitis

Directions to Hospitals Treating Microscopic colitis

Risk calculators and risk factors for Microscopic colitis

Healthcare Provider Resources

Symptoms of Microscopic colitis

Causes & Risk Factors for Microscopic colitis

Diagnostic studies for Microscopic colitis

Treatment of Microscopic colitis

Continuing Medical Education (CME)

CME Programs on Microscopic colitis

International

Microscopic colitis en Espanol

Microscopic colitis en Francais

Business

Microscopic colitis in the Marketplace

Patents on Microscopic colitis

Experimental / Informatics

List of terms related to Microscopic colitis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Synonyms and keywords:

Overview

Microscopic colitis refers to two medical conditions which cause diarrhoea: collagenous colitis and lymphocytic colitis. Both conditions are characterised by the following triad of clinicopathological features:

  1. Chronic watery diarrhoea;
  2. Normal colonoscopy;
  3. Characteristic histopathology.

Historical Perspective

Classification

Pathophysiology

The hallmark of microscopic colitis is an increase in inflammatory cells (i.e. lymphocytes) in colonic biopsies with an otherwise normal appearance and architecture of the colon. Inflammatory cells are increased both in the surface epithelium ("intraepithelial lymphocytes") and in the lamina propria. In lymphocytic colitis, these are the only abnormal features.

In collagenous colitis, the features of lymphocytic colitis are present, with in addition the presence of a thickened subepithelial collagen layer which may be up to 30 micrometres thick.

Microscopic colitis in some cases may be an adverse reaction to drugs or an autoimmune disorder.[1]

Causes

Differentiating Microscopic Colitis from other Diseases

Epidemiology and Demographics

Age

Patients are characteristically middle-aged.

Gender

Patients are characteristically, though not exclusively female.

Race

Risk Factors

Natural History, Complications and Prognosis

The prognosis for lymphocytic colitis and collagenous colitis is good and both conditions are considered to be benign.[2] The majority of people afflicited with the conditions recover from their diarrhoea and their histological abnormalities resolve.[3]

Diagnosis

Diagnostic Criteria

Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Colonoscopy is normal or near normal. The changes are often patchy, so multiple colonic biopsies must be taken in order to make the diagnosis. A full colonoscopy is required, as an examination limited to the rectum will miss cases of microscopic colitis.

Treatment

Medical Therapy

No single treatment is accepted as the standard and measuring response is difficult. Often a trial of anti-diarrhoeals is followed by anti-inflammatory drugs.

Lymphocytic colitis is thought to respond well to mesalazine and collagenous colitis to budesonide.[3]

Surgery

Prevention

References

  1. Macaigne G, Lahmek P, Locher C, Lesgourgues B, Costes L, Nicolas MP; et al. (2014). "Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study". Am J Gastroenterol. 109 (9): 1461–70. doi:10.1038/ajg.2014.182. PMID 25001258.
  2. Mullhaupt B, Güller U, Anabitarte M, Güller R, Fried M (1998). "Lymphocytic colitis: clinical presentation and long term course". Gut. 43 (5): 629–33. PMID 9824342.
  3. 3.0 3.1 Fernández-Bañares F, Salas A, Esteve M, Espinós J, Forné M, Viver J (2003). "Collagenous and lymphocytic colitis. evaluation of clinical and histological features, response to treatment, and long-term follow-up". Am J Gastroenterol. 98 (2): 340–7. PMID 12591052.

Template:WH Template:WS